コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 fibrinogen can serve as a accurate model for plasma fibrinogen.
2 e from retraction with normal recombinant or plasma fibrinogen.
3 -sensitivity C-reactive protein (hsCRP), and plasma fibrinogen.
4 opportunity to establish the source of human plasma fibrinogen.
5 s in the presence of a high concentration of plasma fibrinogen.
6 ly responsible for the depressed levels of a plasma fibrinogen.
7 protein cholesterol, C-reactive protein, and plasma fibrinogen.
8 remained the same over a wide range of total plasma fibrinogen.
9 ell-mediated retraction of clots formed from plasma fibrinogen.
11 ; (2) binds to PECAM-1; (3) does not consume plasma fibrinogen; (4) accumulates in mouse lungs after
12 apolipoprotein B (1.03, 1.06, and 1.08 g/L), plasma fibrinogen (8.43, 8.44, and 9.53 micromol/L), hom
16 closely associated with the extravasation of plasma fibrinogen and activation of the fibrinogen-BMP-S
17 of a kindred with renal amyloidosis and low plasma fibrinogen and also the first report of amyloidos
18 effort that led to a successful outcome for plasma fibrinogen and discusses implications for future
20 FIB-test MCF has strong correlation with plasma fibrinogen and factor XIII level (r = 0.84 and 0.
21 We have investigated associations between plasma fibrinogen and factors operating in childhood and
24 the vessel wall may therefore interact with plasma fibrinogen and promote platelet adhesion, leading
27 polymerase chain reaction, and serology, and plasma fibrinogen and serum interleukin-6 (IL-6) were de
28 s the ligand binding site, which can bind to plasma fibrinogen and to a number of Arg-Gly-Asp (RGD)-t
29 lammatory markers [C-Reactive Protein (CRP), plasma fibrinogen and white blood cells (WBC)] in the as
30 anied by thrombin generation, consumption of plasma fibrinogen, and deposition of hepatic fibrin.
31 indexes of blood rheology (plasma viscosity, plasma fibrinogen, and hematocrit) in 106 patients with
33 The authors have reported previously that plasma fibrinogen appears to rise after menopause and to
36 als were also found to have higher levels of plasma fibrinogen at the time of surgery, with unchanged
37 ant recombinant fibrinogens were compared to plasma fibrinogens by following the time course of throm
38 f hyperfibrinogenemia, we show that elevated plasma fibrinogen concentration (1) elicits augmented fi
39 5 %, p= 0.038), with a parallel reduction of plasma fibrinogen concentration (mean (+/-SD), 157(+/-19
40 (sight impairment), physiological function (plasma fibrinogen concentration and lung function), cogn
43 complication in neurosurgical patients, and plasma fibrinogen concentration has been identified as a
47 o ICR mice did not significantly deplete the plasma fibrinogen concentration, co-administration of Dr
48 cidate the mechanism responsible for the low plasma fibrinogen concentration, simultaneous metabolic
51 ymptoms of amyloidosis as yet but have lower plasma fibrinogen concentrations when compared with thei
52 blood platelet aggregation was enhanced, and plasma fibrinogen content, clot weight, and clot strengt
53 essed the acute phase response and decreased plasma fibrinogen, D-dimer, and proinflammatory cytokine
54 ise, neither decreased RBC ATP nor increased plasma fibrinogen explained the T/HS-induced changes tha
55 ping plaques, and the identification of high plasma fibrinogen (Fib) levels as an independent risk fa
59 s of fibrinogen matrices prepared from human plasma fibrinogen (hFg), recombinant normal (rFg), and f
61 idemiologic studies have correlated elevated plasma fibrinogen (hyperfibrinogenemia) with risk of car
63 pes, and although the liver is the source of plasma fibrinogen in vivo in rats, this is not known in
64 plete clot lysis and complete destruction of plasma fibrinogen; in contrast, rSKDelta59 produced tota
67 that a previously identified calcium site in plasma fibrinogen is absent when Gly-His-Arg-Pro-amide i
72 D for 14 days induced microhemorrhages where plasma fibrinogen leaked into perivascular spaces, but i
73 vealed lower PI in patients with an elevated plasma fibrinogen level (> or =375 mg/dl), diabetes mell
74 ess level remained inversely associated with plasma fibrinogen level (beta = -1.3, 95% confidence int
76 the association between physical fitness and plasma fibrinogen level in 193 children 4-25 years old;
79 ogen concentrate infusion dosed to achieve a plasma fibrinogen level of 2.5 g/L in high-risk cardiac
81 least 1.61 micromol/L (> or =45.3 mg/dL), a plasma fibrinogen level of at least 10.35 micromol/L, a
82 o fib(+/-) littermate controls, which have a plasma fibrinogen level that is 70% of that of wild-type
83 sed plasma markers of coagulation, decreased plasma fibrinogen level, and widespread tissue fibrin de
84 al profile, including normal platelet count, plasma fibrinogen level, clotting time and fibrin crossl
85 did not show any major differences including plasma fibrinogen level, prothrombin time, and activated
88 Our findings indicate that Cv-PC increases plasma fibrinogen levels and may provide a promising the
93 highlights the use of pulmonary rather than plasma fibrinogen levels as a risk indicator for severe
95 ultiple linear regression analyses adjusting plasma fibrinogen levels for age, sex, race/ethnicity, t
97 identified numerous regions associated with plasma fibrinogen levels in Europeans, yet missing herit
100 tests in a real data example of analysis of plasma fibrinogen levels in the TOPMed program (n = 23,7
102 platelet aggregability, we hypothesized that plasma fibrinogen levels may interact with Pl(A) genotyp
103 0/270 mice were hypofibrinogenemic with ~10% plasma fibrinogen levels relative to FgaWT/WT mice, link
106 The ancrod regimen was designed to decrease plasma fibrinogen levels to 1.18 to 2.03 micromol/L.
107 n of fibrin(ogen) in mice, low postoperative plasma fibrinogen levels were associated with liver dysf
108 r the measurement of serum hsCRP levels, and plasma fibrinogen levels were determined using an automa
111 k, only mildly low platelet counts, elevated plasma fibrinogen levels, and detection of both severe a
112 understand the genetic landscape regulating plasma fibrinogen levels, we meta-analyzed WGS data from
116 re associated with a 7% lifelong increase in plasma fibrinogen levels; however, these genetic variant
120 mer position of disulfide bond reduced human plasma fibrinogen prepared from fresh single donor or ou
121 generated from several purified fractions of plasma fibrinogen, purified proteolytic fragments of pla
122 ation after multivariable adjustment between plasma fibrinogen quintiles and risk of DVT alone (P-tre
125 ibrinogen, purified proteolytic fragments of plasma fibrinogen, recombinant normal fibrinogen, and re
126 and addition of HOCl-oxidized fibrinogen to plasma fibrinogen solution disrupted lateral aggregation
127 ntal stress testing in the laboratory, where plasma fibrinogen stress responses were smaller in happi
129 In this work, a device for measuring blood plasma fibrinogen using chromatography paper was develop
131 brinogen can serve as a functional model for plasma fibrinogen, we have examined the conversion of fi
135 able biomarker profiles (C-reactive protein, plasma fibrinogen, white blood cell count, vitamin D, hi
136 We examined the association of baseline plasma fibrinogen with future risk of myocardial infarct